![]() |
-- Exploratory Phase 2 MS & ALS Studies with FLX-787 Underway --
-- Exploratory Phase 2 MS & ALS Studies with FLX-787 Underway --
Flex Pharma Reports Third Quarter 2 16 Financial Results | Business Wire |
All times are GMT -5. The time now is 06:21 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.